Cargando…
Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies
There is no uniform standard of care for the treatment of refractory or recurrent primary central nervous lymphoma (r/r PCNSL). Many different systemic treatment regimens have been studied, but available data are based on small prospective or retrospective reports. There have been no randomized cont...
Autores principales: | Holdhoff, Matthias, Wagner-Johnston, Nina, Roschewski, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445492/ https://www.ncbi.nlm.nih.gov/pubmed/32903865 http://dx.doi.org/10.2147/OTT.S192379 |
Ejemplares similares
-
Current and Emerging Pharmacotherapies for Primary CNS Lymphoma
por: Prodduturi, Prathima, et al.
Publicado: (2012) -
SL3 PRIMARY CNS LYMPHOMA: CURRENT CONCEPTS AND THERAPEUTIC PERSPECTIVES
por: Grommes, Christian
Publicado: (2019) -
Preventing central nervous system spread in diffuse large B-cell lymphoma – novel approaches needed
por: Roschewski, Mark
Publicado: (2021) -
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
por: Downs, Bradley M., et al.
Publicado: (2021) -
Primary CNS Lymphoma
por: Phillips, Elizabeth H., et al.
Publicado: (2014)